Aurinia Pharmaceuticals Inc Ordinary Shares Stock Performance

Open N/A	Prev. Close N/A	Circuit Range N/A
Day Range N/A	Year Range N/A	Volume N/A
Average Traded N/A

Aurinia Pharmaceuticals Inc Ordinary Shares Share Price Chart

$0.00$0.00

Aurinia Pharmaceuticals Inc Ordinary Shares Stock Fundamentals & Key Indicators

Market Cap N/A	PE Ratio (TTM) N/A	Dividend Yield N/A
EPS (TTM) $2.14	Revenue (TTM) $283.06M	Return On Equity (TTM) 49.40%
Profit Margin 101.47%	Debt to Equity 0.16	Quarterly Earnings Growth YoY 119.87%

Aurinia Pharmaceuticals Inc Ordinary Shares Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	N/A	$57.19M	$67.77M	$62.47M	$70.01M	$73.47M
Net Profit	-$10.75M	$722000.00	$14.35M	$23.34M	$21.51M	$31.55M
Net Profit Margin	N/A	1.26%	21.17%	37.37%	30.73%	42.95%
Income Change	N/A	106.72%	1887.53%	62.68%	-7.84%	46.66%

Aurinia Pharmaceuticals Inc Ordinary Shares Annual Profit & Loss

All figures in USD

Particulars	2022	2024	2025
Revenue	$134.03M	$235.13M	$283.06M
Net Profit	-$108.18M	$5.75M	$287.20M
Net Profit Margin	-80.71%	2.45%	101.47%
Income Change	N/A	105.32%	4893.08%

About Aurinia Pharmaceuticals Inc Ordinary Shares

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs. It offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. The company also develops AUR200, a dual inhibitor of B cell activating factor and a proliferation inducing ligand for the potential treatment of autoimmune diseases. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc Ordinary Shares Historical Returns

Month	Open	Close	Change %

AUPH Share Price FAQs

What is Aurinia Pharmaceuticals Inc Ordinary Shares share price today?

Aurinia Pharmaceuticals Inc Ordinary Shares share price today is $0.00 as on August 9, 2026 at 6:12 pm IST.

What is the 52 week high and 52 week low of Aurinia Pharmaceuticals Inc Ordinary Shares stock?

52 week high/low data for Aurinia Pharmaceuticals Inc Ordinary Shares is currently unavailable.

What is AUPH's net income for the last quarter?

AUPH's net income for the last quarter is 0.03B USD.

Can I buy AUPH shares in India?

Yes. You can buy AUPH in India by opening an international trading account.